QEI
GMED icon

QSV Equity Investors’s Globus Medical GMED Stock Holding History

QSV Equity Investors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.47M Sell
16,832
-7,420
-31% -$563K 2.17% 3
2025
Q3 		$1.39M Hold
24,252
– – 1.42% 32
2025
Q2 		$1.43M Buy
24,252
+8,551
+54% +$552K 1.49% 28
2025
Q1 		$1.15M Sell
15,701
-35
-0.2% -$2.89K 1.19% 49
2024
Q4 		$1.3M Hold
15,736
– – 1.25% 45
2024
Q3 		$1.13M Hold
15,736
– – 1.06% 55
2024
Q2 		$1.08M Sell
15,736
-91
-0.6% -$5.44K 1.12% 53
2024
Q1 		$849K Buy
15,827
+176
+1% +$9.46K 0.82% 59
2023
Q4 		$834K Buy
+15,651
New +$763K 0.81% 60

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

QSV Equity Investors's GMED Position: Q4 2025 in Review

QSV Equity Investors reduced its Globus Medical (GMED) stake by 31% in Q4 2025, selling an estimated $563K and leaving 16,832 shares worth $1.47M. The position accounts for 2.17% of the portfolio, ranked #3.

QSV Equity Investors first reported a position in GMED in Q4 2023 and has held it in 9 quarters since. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • QSV Equity Investors held 16,832 shares of Globus Medical worth $1.47M as of Q4 2025.
  • QSV Equity Investors sold 7,420 Globus Medical shares in Q4 2025, an estimated $563K.
  • Globus Medical made up 2.17% of QSV Equity Investors's portfolio in Q4 2025, its #3 holding.
  • QSV Equity Investors first reported a position in Globus Medical in Q4 2023 and has held it in 9 quarters since.
  • 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.